中国药物输送设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

中国药物输送设备市场按设备类型、治疗应用和销售渠道细分

市场快照

CAGR
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 9.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,中国药物输送设备市场预计将录得 9.3% 的复合年增长率。推动中国给药装置市场增长的主要因素是慢性病负担的增加、益处和便利性,导致对自我注射器的需求增加,以及生物市场的增长,导致对给药装置的需求增加. 慢性病的日益流行导致药物输送装置的使用增加,特别是一次性注射器。许多慢性病导致的死亡可能与癌症、心脏病、超重和糖尿病有关。

根据中华人民共和国国务院新闻办公室的数据,每年医生诊断出2.6亿人患有慢性病。慢性病每年占中国死亡人数的 85%。导致大多数死亡的疾病是癌症(27.79%)、脑血管疾病(20.22%)和心脏病(21.3%)。预计这将影响市场,人口增长是影响市场的因素之一,因为人口增长被认为是该国最重要的因素。帮助药物输送设备市场增长的另一个因素是技术的不断进步,这可能是预测期内推动市场增长的关键因素之一。

Scope of the report

Drug delivery systems are the medical equipment and devices used to deliver the medicines to human bodies and different systems. These are specifically designed to administer the specific drugs in accordance with the different techniques of administration. Such tools are used for therapeutic procedures and the whole process of healing.

By Device Type
Nasal
Inhalers
Other Device Types
Implantable
Injectable
Conventional Drug Delivery Devices
Self-injectable Drug Delivery Devices
Prefilled Syringes
Auto Injectors
Other Self-injectable Drug Delivery Devices
Other Dvice Types
By Therapeutic Application
Cardiovascular
Oncoloy
Autoimmune Disorder
Pulmonary Disease
Other Therapeutic Applications
By Sales Channel
Hospitals
Pharmacy
Other Sales Channels

Report scope can be customized per your requirements. Click here.

主要市场趋势

自注射给药装置板块有望在中国给药装置市场占有重要份额

自注射设备的创新和发展无止境,推动了该国市场的增长。与自注射注射剂相关的其他主要优点是发现它们使用方便且成本低。这些是适应性最强的设备,具有高精度的药物输送,并且易于使用。除此之外,随着自注射设备的创新,这些产品的接受度在过去几年中有所增加。尽管如此,自注射剂的优势和提高自我管理意识可能有助于推动预测期内的整体市场增长。

picture 123.png

竞争格局

中国药物输送设备市场竞争激烈,由多个参与者组成。就市场份额而言,目前主导市场的主要企业寥寥无几,一些知名企业正在大力与其他公司进行收购和合资,以巩固其在该国的市场地位。目前主导市场的一些公司是 Gerresheimer AG、辉瑞公司、F. Hoffmann-La Roche AG、Becton、Dickinson and Company 和 Teva Pharmaceutical Industries Ltd.。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Prevalence of Chronic Diseases

      2. 4.2.2 Advancement in Technology

    3. 4.3 Market Restraints

      1. 4.3.1 The High Cost of Development

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device Type

      1. 5.1.1 Nasal

        1. 5.1.1.1 Inhalers

        2. 5.1.1.2 Other Device Types

      2. 5.1.2 Implantable

      3. 5.1.3 Injectable

        1. 5.1.3.1 Conventional Drug Delivery Devices

        2. 5.1.3.2 Self-injectable Drug Delivery Devices

          1. 5.1.3.2.1 Prefilled Syringes

          2. 5.1.3.2.2 Auto Injectors

          3. 5.1.3.2.3 Other Self-injectable Drug Delivery Devices

      4. 5.1.4 Other Dvice Types

    2. 5.2 By Therapeutic Application

      1. 5.2.1 Cardiovascular

      2. 5.2.2 Oncoloy

      3. 5.2.3 Autoimmune Disorder

      4. 5.2.4 Pulmonary Disease

      5. 5.2.5 Other Therapeutic Applications

    3. 5.3 By Sales Channel

      1. 5.3.1 Hospitals

      2. 5.3.2 Pharmacy

      3. 5.3.3 Other Sales Channels

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Gerresheimer AG

      2. 6.1.2 Pfizer Inc.

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Teva Pharmaceutical Industries Ltd

      6. 6.1.6 Merck & Co. Inc.

      7. 6.1.7 Novartis International AG

      8. 6.1.8 Sanofi SA

      9. 6.1.9 GlaxoSmithKline PLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Drug Delivery Devices Market market is studied from 2018 - 2026.

The China Drug Delivery Devices Market is growing at a CAGR of 9.3% over the next 5 years.

Gerresheimer AG, Pfizer Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd. are the major companies operating in China Drug Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!